Juan Alberto Guevara-Salazar (J Alberto Guevara-Salazar, Juan Alberto Guevara Salazar)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Venues

Chemistry & biodiversity

Expert opinion on drug discovery

Pharmaceuticals (Basel, Switzerland)

Expert review of anti-infective therapy

Instituto Politécnico Nacional

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto Politécnico Nacional Aug 01 2006

Mexico

Ph.D. :: Academia de Farmacología

Publications

Hugo A Jiménez-Vázquez, Juan Alberto Guevara-Salazar, Delia Quintana-Zavala
Synthesis, Theoretical Study, and Anticonvulsant Evaluation of N-Arylenaminones. Chemistry & biodiversity 21 (5) (2024)
Hugo A Jiménez-Vázquez, Juan Alberto Guevara-Salazar, Delia Quintana-Zavala
Synthesis, Theoretical Study, and Anticonvulsant Evaluation of N-Arylenaminones. Chemistry & biodiversity 21 (5) (2024)
Hugo A Jiménez-Vázquez, Juan Alberto Guevara-Salazar, Delia Quintana-Zavala
Synthesis, Theoretical Study, and Anticonvulsant Evaluation of N-Arylenaminones. Chemistry & biodiversity (2024)
Hugo A Jiménez-Vázquez, Juan Alberto Guevara-Salazar, Delia Quintana-Zavala
Synthesis, Theoretical Study, and Anticonvulsant Evaluation of N-Arylenaminones. Chemistry & biodiversity 21 (5) (2024)
Irving Balbuena-Rebolledo, Astrid M Rivera-Antonio, Yudibeth Sixto-López, Correa-Basurto José, Martha Cecilia Rosales-Hernández, Jessica Elena Mendieta-Wejebe, Francisco J Martínez-Martínez, Ivonne María Olivares-Corichi, José Rubén García-Sánchez, Juan Alberto Guevara-Salazar, Martiniano Bello, Itzia Irene Padilla-Martínez
Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Jessica Rubí Morán Díaz, Juan Alberto Guevara-Salazar, Roberto Issac Cuevas Hernández, José Guadalupe Trujillo Ferrara
A more specific concept of a pharmacophore to better rationalize drug design, tailor patient therapy, and tackle bacterial resistance to antibiotics. Expert opinion on drug discovery (2021)
Juan Alberto Guevara-Salazar, Jessica Rubí Morán Díaz, Enrique Ramírez Segura, José Guadalupe Trujillo Ferrara
What are the origins of growing microbial resistance? Both Lamarck and Darwin were right. Expert review of anti-infective therapy 19 (5) (2020)

Juan Alberto Guevara-Salazar.css-eqlu8i{font-size:small;padding-left:4px;} (J Alberto Guevara-Salazar, Juan Alberto Guevara Salazar)

Publication Activity (10 Years)

Top Topics

Top Venues

Juan Alberto Guevara-Salazar (J Alberto Guevara-Salazar, Juan Alberto Guevara Salazar)